Literature DB >> 21655775

Hydroxyapatite crystallinity does not affect the repair of critical size bone defects.

Marcio Baltazar Conz1, José Mauro Granjeiro, Gloria de Almeida Soares.   

Abstract

OBJECTIVE: The physicochemical properties of hydroxyapatite (HA) granules were observed to affect the biological behavior of graft materials. The aim of this work was to analyze the tissue response of two HA granules with different crystallinity and Ca/P ratio in vivo.
MATERIAL AND METHODS: The HA granules were produced in the Biomaterials Laboratory (COPPE/UFRJ). The testing materials were HA granules presenting a Ca/P molar ratio of 1.60 and 28% crystallinity (HA-1), and a Ca/P molar ratio of 1.67 and 70% crystallinity (HA-2). Both HAs were implanted into a critical-size calvaria rat defects.
RESULTS: To note, in the control group, the bone defects were filled with blood clot only. Descriptive and histomorphometric analyses after 1, 3, and 6 months postoperatively showed mild inflammatory infiltrate, mainly comprising macrophage-like and multinucleated giant cells, and an increase in the volume density of the fibrous tissues (p<0.05), which was in contrast to the similar volume density of the newly formed bone and biomaterials in relation to the control group.
CONCLUSION: Thus, we concluded that HA-1 and HA-2 are biocompatible and non-degradable, and that crystallinity does not affect bone repair of critical size defects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21655775      PMCID: PMC4223784          DOI: 10.1590/s1678-77572011005000007

Source DB:  PubMed          Journal:  J Appl Oral Sci        ISSN: 1678-7757            Impact factor:   2.698


INTRODUCTION

In the last decade, great progress was made in the use of grafts in dentistry with the development of the biomaterials that became indispensable for professionals in the areas of bucomaxillofacial surgery, paraendodontic surgery, orthognathic and implants surgery[13]. Bone loss owing to trauma or disease is not only a major socio-economic burden on world healthcare systems, but also results in a reduced quality of life for the patient. Current strategies for repair include bone autograft and allograft, both of which have inherent limitations such as limited supply, increased morbidity, and disease transmission potential[18]. In this scenario, calcium phosphate (Ca-P) porous ceramics had gained acceptance and these are used in medical-dentistry fields in order to promote bone regeneration, increase, or substitution[3]. Calcium phosphate materials can be found in nature (coralline hydroxyapatite) or can be synthesized by precipitation methods using chemical reagents. Hydroxyapatite (HA), Ca10(PO4)6(OH)2, is the well-known and widely studied Ca-P[12]. In both medical and dental routine, the term "hydroxyapatite" is sometimes used to describe any Ca-P material. Synthetic Ca-P grafts may be the material of choice, especially when large defects need to be filled. It is generally accepted that these bioceramics are only osteoconductive (have the ability to support tissue growth and bone formation) and non-osteoinductive, i.e., they do not have the ability to form new bones when implanted in non-osseous sites[17]. Based on their physic-chemical properties, the bone-graft material may be either resorbable or non-resorbable, with respect to the extent of dissolution of Ca-P materials. The factors affecting the dissolution properties are similar to those affecting biodegradation or bioresorption[5,12,17]. Among other physicochemical characteristics, HA crystallinity and Ca/P molar ratio have been reported to affect its solubility[1,3,23], protein adsorption, and osteoblast attachment[28], possibly compromising biological responses. However, no in vivo data are available in the literature. In order to achieve this point, the aim of this work is to analyze the tissue response of two HA granules with different physicochemical properties in critical-size calvaria rat defects[4].

MATERIAL AND METHODS

Material

The HA (HA-1 and HA-2) granules (250-1000 µm) were obtained from the HA powder, produced from reactive calcium phosphates at room temperature, in the Biomaterials Laboratory, COPPE, Federal University of Rio de Janeiro (Rio de Janeiro, RJ, Brazil). Previous analysis showed that HA-1 granules presented a Ca/P molar ratio of 1.6 and 28% crystallinity, while the HA-2 granules had a Ca/P molar ratio of 1.67 and 70% crystallinity, as determined by chemical analysis and x-ray diffraction (XRD), respectively (Figure 1). Morphological characterization of the materials was carried out with the help of scanning electron microscopy (Zeiss, model DSM 940A, Oberkochen, Baden-Württemberg, Germany) operating at 20 kV of electron acceleration. To identify the crystalline phases in the biomaterials, an x-ray diffractometer (DRX-Miniflex, Rigaku, Tokyo, Japan) was used, which operated at 30 kV, 15 mA, and CuKα radiation. The crystallinity of the materials was determined from the DRX patterns according to the methodology proposed by Landi, et al.[16] (2000).
Figure 1

HA-1 and HA-2 x-ray diffraction (XRD)

HA-1 and HA-2 x-ray diffraction (XRD)

Surgical procedures

The ethics committee of Bauru School of Dentistry, University of São Paulo (USP) approved the protocol of the surgical intervention (CEEPA - Nº 18/2004). All the procedures were followed under rules of Brazilian College of Animal Experimentation (COBEA). Forty-five adult Rattus norvegicus (250 g body weight) were submitted to skull surgery under general anesthesia with intramuscular administration of xylazine/ketamine (v:v, AgriBrands LtdaTM, Paulinia, SP, Brazil). Briefly, after local trichotomy of the frontoparietal region and vigorous disinfection with iodoform alcohol, the surgical area was isolated and a half moon-shaped incision was made in the lining epithelium of the skull with a #10 surgical knife. The flap was then raised backwards with a Molt spatula, thus widely exposing the bone surface of the skull. Using a surgical trephine (8 mm in diameter), a perforation was made in the parietal bone, under abundant and continuous irrigation with saline solution to avoid any thermal injury, crossing the entire diploe and exposing the dura mater at the bottom of the defect. The defects were filled with blood clot, HA-1, and HA-2 in 15 animals each. Nylon sutures (EthiconTM, Johnson & Johnson, São José dos Campos, SP, Brazil) were employed to close the reposed flap of each animal. The animals received water and pelleted food ad libitum.

Histological processing

The rats were killed by an overdose of the anesthetic agent after 1, 3, and 6 months of surgery. The skullcaps with overlaying skin were collected and fixed in 10% phosphate buffered formalin for one week, demineralized in Morse solution (50% formic acid and 20% sodium citrate, 1:1) for 40 days, dehydrated in ethanol, cleared with xylene, and embedded in HistosecTM (Merck, Darmstadt, Germany). Hematoxylin-eosin stained 5-μm thick semi-serial section was used for descriptive and histomorphometric analysis.

Descriptive histological analysis

Using an AxioscopTM (Carl Zeiss, Darmstadt, Germany), we evaluated the presence of blood clots and inflammatory infiltrates, the intensity of angiogenesis, formation of fibrous tissues, resorption of graft material, reorganization of the periosteum, and bone formation and remodeling.

Histomorphometric and statistical analysis

We determined the volume density of connective tissue, neoformed bone, and biomaterial on non-superposed digital images of the total area of the bone defect obtained using Sony Cyber-Shot (P-83, Tokyo, Japan) digital camera coupled to a microscope (Jenaval-Zeiss, Darmstadt, Germany) under 20× objective (N.A. 0.55). The digital images (1280×960 pixels) segmentation allowed determination of the total image area and relative area of the connective tissue, biomaterial, and neoformed bone. Kruskall-Wallis or Mann-Whitney tests determined the existence of significant differences (if p<0.05) among the volume density of each parameter.

RESULTS

The procedures were well tolerated by all experimental animals and no complications were observed after surgery.

Descriptive microscopic analysis

In summary, all groups presented fibrous connective tissues fulfilling the critical-size defect and sparse neoformed bone areas were observed in all the animals, mainly at the edge of defect. No significant difference was noticed between HA-1 and HA-2 and dense connective tissues surrounded the biomaterials granules except for some particles where a directed bone apposition to HA occurred. Tissue response to biomaterials, irrespective of crystallinity and Ca/P molar ratio, presented foreign body reaction with multinucleated and macrophage-like cells, occasionally observed in contact with the biomaterials. Animals from control group, one month after surgery, presented a typical chronic inflammatory infiltrate with a few polymorphonuclear leucocytes close to the blood vessels and mononuclear cells (macrophages-like cells), as showed in the Figure 2A. The presence of polymorphonuclear cells and mast cells was similar in HA-1, HA-2 and control groups (Figure 2C). The macrophages were more abundant surrounding the HA granules, it being multinucleated giant cells (Figure 2C).
Figure 2

Photomicrography of rat skulls at the periods of 1 and 6 months. A) Control group (blood clot), 1 month; the interface between old bone (OB) and new bone (NB) presents a line (arrow); asterisk (*) shows the connective tissue. B) Control group, 6 months; the old bone (OB) and new bone (NB) separated by connective tissue; interestingly, an animal of five presented endochondral ossification in the center of the bone defect (inner figure). C) HA-1 group, 1 month; presence of new bone (NB) and multinucleated giant cells (arrows) and connective tissue (*) were observed surrounding HA particles and new bone (NB); D) After 6 months, a fibrous connective tissue (FCT) was enriched by newly-formed blood vessels (arrows) and multinucleated giant cells in contacting HA particles (circle). E) Section showing the border of the bone defect presenting old bone (OB) – new bone (NB) interface (straight line) and HA-2 particles (*) surrounded by fibrous connective tissue (FCT) close to the border and at the center of critical size defect. Magnifications: 40x (A, C, D, inner figure in B); 12.5x (B, E)

Photomicrography of rat skulls at the periods of 1 and 6 months. A) Control group (blood clot), 1 month; the interface between old bone (OB) and new bone (NB) presents a line (arrow); asterisk (*) shows the connective tissue. B) Control group, 6 months; the old bone (OB) and new bone (NB) separated by connective tissue; interestingly, an animal of five presented endochondral ossification in the center of the bone defect (inner figure). C) HA-1 group, 1 month; presence of new bone (NB) and multinucleated giant cells (arrows) and connective tissue (*) were observed surrounding HA particles and new bone (NB); D) After 6 months, a fibrous connective tissue (FCT) was enriched by newly-formed blood vessels (arrows) and multinucleated giant cells in contacting HA particles (circle). E) Section showing the border of the bone defect presenting old bone (OB) – new bone (NB) interface (straight line) and HA-2 particles (*) surrounded by fibrous connective tissue (FCT) close to the border and at the center of critical size defect. Magnifications: 40x (A, C, D, inner figure in B); 12.5x (B, E) The intensity of the inflammatory infiltrate decreased after 3 months of implantation, particularly concerning the presence of macrophages, but with increased incidence of multinucleated foreign body giant cells in both HA-1 and HA-2 groups (not shown). Polymorphonuclear cells were absent in all sections evaluated. The inflammatory infiltrate disappeared in control group, it being that just an animal (from group of five) showed new bone in the center of the defect after six months (Figure 2B). In both HA-1 and HA-2 groups the microscopic aspects were similar to previous period, presenting mononuclear cells scattered through the dense connective tissue and multinucleated foreign body giant cells around both types of HA particles (Figure 2D and E).

Histomorphometric analysis

Throughout the experimental periods (Table 1), the volume density of connective tissue in the control group was almost twice greater than HA-1 and HA-2 groups (p=0.012, Student-Newman-Keuls test). The volume density of bone between tested groups did not change significantly at any experimental period remaining around 30% after six months. Temporal analysis from one to three months for volume density of connective tissue, bone and HA-1 and HA-2 showed no significant difference (Table 1).
Table 1

Mean percentage (± standard deviation) of the volume density of bone, fibrous connective tissue and residual biomaterial at 1, 3, and 6 months after implantation in critical size bone defect (ANOVA and Tukey test if p<0.05)

Analyzed StructureExperimental Groups and Periods (months)
 Control groupHA-1HA-2
 136136136
Bone22.2±13.421.8±9.532.4±13.015.2±4.725.9±24.727.2±18.021.2±24.021.1±3.932.0±28.7
Fibrous tissue77.7±13.478.1±9.567.5±13.045.7±7.246.6±11.246.6±10.537.3±17.548.1±7.641.0±17.0
Biomaterial00038.9±11.827.3±14.1426.0±9.141.3±8.030.7±4.226.9±11.8
Mean percentage (± standard deviation) of the volume density of bone, fibrous connective tissue and residual biomaterial at 1, 3, and 6 months after implantation in critical size bone defect (ANOVA and Tukey test if p<0.05)

DISCUSSION

Synthetic and natural Ca-P-based materials may be a suitable alternative to autogenous graft[19]. With various bone grafting options available to the surgeons, one must carefully match the clinical problem with the capabilities of graft material. Sintering process provides strength to a finished material, but when applied to bone, decreases remodeling and resorption capability of the biomaterial[11,12]. Among several factors, chemical composition, particles size, and crystallinity are likely to affect the ceramic solubility, which can be adjusted for the desired purpose[7,8]. Different applications require materials with different resorption rates, which can be regulated by the mixture of several Ca-P phases[17]. Crystallinity is highly dependent on the sintering temperature - the high sintering temperature results in more perfect crystal, and thus, the degradation rate is lesser[28]. On the other hand, more extensive interconnected porosity of materials permits faster bone growth, but it becomes the material weaker; the ideal pore size is considered to be between 150 and 500 microns[2,9], like those ones naturally designed[30]. Industrially, the degree of microporosity depends on the compaction process of the starting powder and the temperature for producing engineered materials. The presence of pores in the granules increases the surface area in the biomaterials, favoring osteoconduction, and also enabling bone growth in the pores[30]. The HA granules, from both HA-1 and HA-2 groups, presenting different crystallinity (28 and 78%, respectively) and Ca/P molar ratio (1.60 and 1.67, respectively) should present differential biological response. Thus, the positive hypothesis was that less crystalline and calcium-deficient hydroxyapatite (HA-1) presents bigger degradability than others. Despite many in vivo models available for biocompatibility assay, only critical size defect studies allow the determination of biomaterial efficacy[6,25]. Critical size defect varies in relation to the animal species, localization and animal age; in rat calvaria bone defect of 5 mm4 and 8 mm10 have been widely used. Based on our results, this work supports previous studies that concluded that bone defects of 8 mm diameter did not allow self regeneration up to six months[5,24]. The lack of membrane over the biomaterial for guided bone regeneration (GBR) may explain the high amount of fibrous tissues in the defects[10,21]. As discussed in the current literature, the different densities of fibrous tissues among the experimental groups and control group were related to the HA granules in the defect of the experimental groups[27,31]. GBR has been recognized as a predictable and effective method for enhancing bone healing over a decade, and both animal and human models have illustrated its efficacy[15,29]. It has been shown that the use of absorbable membrane alone was able to fully regenerate a critical size defect[25]. The experimental groups did not show greater bone formation than the control group, and the results are similar to previous studies in humans[14,20,22,26,29] (Table 2). It is worthwhile to mention that in the current literature, synthetic and natural hydroxyapatite promoted similar levels of new bone. The residual bone graft biomaterial in the experimental groups increased the mineral content inside the bone defects and did not interfere with the bone formation, acting as an osteoconductor biomaterial. However, the present work is the first evidence comparing in vivo synthetic hydroxyapatites with low (28%) and high (70%) crystallinity and distinct Ca/P ratio content, showing that intensity of bone repair was independent of these parameters. An explanation of this statement is that one published recently[2]; their results revealed key steps of the mechanism for the bioactivity of hydroxyapatite, which are the solubilization of hydroxyapatite and the equilibrium that is formed on the surface. These processes modify the hydroxyapatite surface, whose composition is changed to a new calcium phosphate compound with the chemical formula of CaHPO4. A clear description of the transformations that occur on the surface of hydroxyapatite and of the interplay between these transformations and cell activity are two fundamental aspects of processes in which hydroxyapatite takes part, such as bone substitution, bone remodeling, osteoporosis and caries.
Table 2

Percentage of bone, fibrous tissue and biomaterial observed in the present and related studies

AuthorBone (%)Fibrous tissue (%)Biomaterial (%)
Conz, et al. (present work)27.246.626.0
Conz, et al. (present work)32.041.026.9
Valentin and Bensur[26] (2003)21.040.039.0
Yildirin, et al.[29] (2000)14.755.629.7
Norton, et al.[22] (2003)26.947.525.6
John and Wenz[14] (2004)29.555.614.9
Meijndert, et al.[20] (2005)17.641.940.5
Percentage of bone, fibrous tissue and biomaterial observed in the present and related studies

CONCLUSION

In conclusion, the different characteristics of HA granules did not affect the bone formation in the critical-size defect of rats, despite their biocompatibility. It is known that sintered biomaterials lead to products virtually not absorbable and, thus, developing new strategies to produce absorbable material tend to improve its efficacy. Taken together, these results guide the material engineer for producing biphasic materials containing beta-TCP and non-sintered hydroxyapatite as a potential material to provide bone growth. Another challenge is the production of mechanically stable scaffolds to support the forces applied during surgical procedures.
  28 in total

Review 1.  Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function.

Authors:  P Ducheyne; Q Qiu
Journal:  Biomaterials       Date:  1999-12       Impact factor: 12.479

2.  Effect of porous xenographic bone graft with collagen barrier membrane on periodontal regeneration.

Authors:  Satoru Yamada; Nobuhiro Shima; Hidekazu Kitamura; Hiroki Sugito
Journal:  Int J Periodontics Restorative Dent       Date:  2002-08       Impact factor: 1.840

3.  Bone quality at the implant site after reconstruction of a local defect of the maxillary anterior ridge with chin bone or deproteinised cancellous bovine bone.

Authors:  L Meijndert; G M Raghoebar; P Schüpbach; H J A Meijer; A Vissink
Journal:  Int J Oral Maxillofac Surg       Date:  2005-06-22       Impact factor: 2.789

4.  Bone repair and augmentation using block of sintered bovine-derived anorganic bone graft in cranial bone defect model.

Authors:  Tania Mary Cestari; José Mauro Granjeiro; Gerson Francisco de Assis; Gustavo Pompermaier Garlet; Rumio Taga
Journal:  Clin Oral Implants Res       Date:  2009-04       Impact factor: 5.977

5.  Resorbable versus nonresorbable membranes in combination with Bio-Oss for guided bone regeneration.

Authors:  N U Zitzmann; R Naef; P Schärer
Journal:  Int J Oral Maxillofac Implants       Date:  1997 Nov-Dec       Impact factor: 2.804

Review 6.  On the repair potential of periodontal tissues.

Authors:  A H Melcher
Journal:  J Periodontol       Date:  1976-05       Impact factor: 6.993

7.  Hydroxyapatite surface solubility and effect on cell adhesion.

Authors:  Sergio Bertazzo; Willian F Zambuzzi; Daniela D P Campos; Thais L Ogeda; Carmen V Ferreira; Celso A Bertran
Journal:  Colloids Surf B Biointerfaces       Date:  2010-03-11       Impact factor: 5.268

8.  Calcium phosphate apatites with variable Ca/P atomic ratio II. Calcination and sintering.

Authors:  S Raynaud; E Champion; D Bernache-Assollant
Journal:  Biomaterials       Date:  2002-02       Impact factor: 12.479

9.  The influence of dispersant concentration on the pore morphology of hydroxyapatite ceramics for bone tissue engineering.

Authors:  L A Cyster; D M Grant; S M Howdle; F R A J Rose; D J Irvine; D Freeman; C A Scotchford; K M Shakesheff
Journal:  Biomaterials       Date:  2005-03       Impact factor: 12.479

10.  Healing of critical-size cranial defects in guinea pigs using a bovine bone-derived resorbable membrane.

Authors:  Márcio Luiz de Lima Taga; Jośe Mauro Granjeiro; Tania Mary Cestari; Rumio Taga
Journal:  Int J Oral Maxillofac Implants       Date:  2008 May-Jun       Impact factor: 2.804

View more
  8 in total

1.  Chlorhexidine-loaded hydroxyapatite microspheres as an antimicrobial delivery system and its effect on in vivo osteo-conductive properties.

Authors:  Carlos Alberto Soriano-Souza; Andre L Rossi; Elena Mavropoulos; Moema A Hausen; Marcelo N Tanaka; Mônica D Calasans-Maia; Jose M Granjeiro; Maria Helena M Rocha-Leão; Alexandre M Rossi
Journal:  J Mater Sci Mater Med       Date:  2015-03-20       Impact factor: 3.896

2.  Morphological and Biological Evaluations of Human Periodontal Ligament Fibroblasts in Contact with Different Bovine Bone Grafts Treated with Low-Temperature Deproteinisation Protocol.

Authors:  Serena Bianchi; Sara Bernardi; Antonella Mattei; Loredana Cristiano; Leonardo Mancini; Diana Torge; Giuseppe Varvara; Guido Macchiarelli; Enrico Marchetti
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

3.  Long-term biocompatibility evaluation of 0.5 % zinc containing hydroxyapatite in rabbits.

Authors:  Rodrigo F B Resende; Gustavo V O Fernandes; Sílvia R A Santos; Alexandre M Rossi; Inayá Lima; José M Granjeiro; Mônica D Calasans-Maia
Journal:  J Mater Sci Mater Med       Date:  2013-04-21       Impact factor: 3.896

4.  SEM-EDX Study of the Degradation Process of Two Xenograft Materials Used in Sinus Lift Procedures.

Authors:  María Piedad Ramírez Fernández; Sergio A Gehrke; Carlos Pérez Albacete Martinez; Jose L Calvo Guirado; Piedad N de Aza
Journal:  Materials (Basel)       Date:  2017-05-17       Impact factor: 3.623

5.  Synthesis and cytotoxicity evaluation of granular magnesium substituted β-tricalcium phosphate.

Authors:  Débora dos Santos Tavares; Leticia de Oliveira Castro; Gloria Dulce de Almeida Soares; Gutemberg Gomes Alves; José Mauro Granjeiro
Journal:  J Appl Oral Sci       Date:  2013 Jan-Feb       Impact factor: 2.698

6.  Clinical observation of biomimetic mineralized collagen artificial bone putty for bone reconstruction of calcaneus fracture.

Authors:  Yong-Xiong Pan; Guang-Gang Yang; Zhong-Wan Li; Zhong-Min Shi; Zhan-Dong Sun
Journal:  Regen Biomater       Date:  2018-02-08

7.  In vivo regeneration functionalities of experimental organo-biomaterials containing water-soluble nacre extract.

Authors:  João César Zielak; David Gulin Neto; Makeli Aparecida Cazella Zielak; Leonardo Brunet Savaris; Fernando Luis Esteban Florez; Tatiana Miranda Deliberador
Journal:  Heliyon       Date:  2018-09-14

8.  The Role of Marine Organic Extract in Bone Regeneration: A Pilot Study.

Authors:  João César Zielak; Ivana Vendramini; Paola Fernanda Cotait de Lucas Corso; Leonardo Luiz Muller; Viviane Rozeira Crivellaro; Sharukh Soli Khajotia; Fernando Luis Esteban Florez; Rafaela Scariot; Mohammed Elsalanty; Tatiana Miranda Deliberador; Carmen Lucia Mueller Storrer
Journal:  Biomed Res Int       Date:  2020-02-17       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.